Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Vistin Pharma AS
AS
Active
Org 813120232
Østensjøveien 27, 0661
Oslo
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2014 · 12 years old
78 employees
Monitor
Share
Norway
/
Companies
/
Manufacture of pharmaceutical preparations
/
Vistin Pharma AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
545M
409M
273M
136M
0M
2020: 254M
254M
2020
2021: 279M (+10% vs 2020)
279M
+10%
2021
2022: 305M (+9% vs 2021)
305M
+9%
2022
2023: 438M (+44% vs 2022)
438M
+44%
2023
2024: 430M (-2% vs 2023)
430M
-2%
2024
EBITDA
NOK millions
137M
103M
68M
34M
0M
2020: 58M
58M
2020
2021: 49M (-16% vs 2020)
49M
-16%
2021
2022: 10M (-80% vs 2021)
10M
-80%
2022
2023: 93M (+830% vs 2022)
93M
+830%
2023
2024: 110M (+18% vs 2023)
110M
+18%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
429 503
438 328
304 852
278 623
253 906
Staff expenses
−90 527
−90 989
−77 010
−71 479
−70 898
EBITDA
110 376
92 921
10 378
48 556
58 190
Depreciation & amort.
−19 029
−17 347
−12 280
−10 609
−9 623
EBIT
91 347
75 574
−1 902
37 947
48 567
Net financials
−6 375
−13 231
−1 733
−2 673
−10 882
Profit before tax
84 972
62 343
−3 635
35 274
37 685
Tax
18 699
13 764
−771
7 620
8 313
Net profit
66 273
48 579
−2 864
27 654
29 372
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
375 980
395 181
404 516
317 792
224 458
Equity
174 320
106 448
54 178
54 831
28 335
Long-term debt
0
58 024
58 024
58 024
98 550
Short-term debt
195 058
221 845
279 114
189 103
81 244
Total debt
195 058
279 869
337 138
247 127
179 794
Financial ratios
5-year trend
EBITDA margin
25,7 %
This company
15,8 %
Market median
This company
Market median
63% above market
2020
2024
Equity ratio
46,4 %
This company
38,2 %
Market median
This company
Market median
21% above market
2020
2024
Return on equity
38,0 %
This company
18,4 %
Market median
This company
Market median
107% above market
2020
2024
Net profit margin
15,4 %
This company
8,1 %
Market median
This company
Market median
90% above market
2020
2024
Asset turnover
1,14×
This company
1,12×
Market median
This company
Market median
2% above market
2020
2024
Debt / equity
1,16×
This company
0,62×
Market median
This company
Market median
87% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Vistin Pharma AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
